Jennifer L. Brogdon BSc, PhD

Jennifer Brogdon, Senior Investigator II in the Immuno-Oncology department of the Novartis Institute for Biomedical Research, oversees the CAR T cell Research Collaboration with the University of Pennsylvania to develop personalized T cell therapies for Oncology. She is also the Research representative for the development program for CTL019. In addition to the CAR work, she is actively engaged in other Immuno-Oncology therapeutic programs in NIBR, Due Diligence efforts and has made significant contributions to a variety of publications and patent applications. She trained in Immunology at Duke University (PhD) and Yale University (Postdoc). Her academic training in T cell biology has been the focus of her drug discovery research since she joined NIBR in 2004.